LC/ESI-MS of oxidation end-products of metformin
899
exchange four times to give an ion at m/z 130.1 (Fig. 13(b)),
in good agreement with the molecular structure of 4,2,1-
AIMT (three exchange sites plus one for protonation). Its
fragmentation leads to ions with masses compatible with
those of the fragments detected in H2O–MeOH (Fig. 13(a)):
fragments at m/z 70.4 and 84.0 can exchange three times
and twice, respectively, to give ions detected at m/z 72.9
and 86.1. These results demonstrate that 4,2,1-AIMT is one
of the primary oxidation end-products of MTF in aqueous
solution.
As shown in Fig. 5, another HPLC peak is detected at m/z
126.1 (tr D 5.4 min), which probably corresponds to a second
oxidation product that has the same mass as 4,2,1-AIMT. A
simple way to find a second molecular structure consists in
assuming the migration of a methyl group from 4,2,1-AIMT
(1), as represented in Fig. 14.
This rearrangement leads to an aromatic molecule, called
2-amino-4-methylamino-1,3,5-triazine (2,4-AMT (2)). The
molecular structure of this second compound is compatible
with the CID spectra presented in Fig. 13. In particular,
the three main losses of 27, 42 and 56 Da observed in
the CID spectrum acquired in the non-labeled medium
(H2O–MeOH) could correspond to each part of 2,4-AMT.
Moreover, the number of H–D exchange sites observed on
the CID spectrum acquired in D2O–MeOD (Fig. 13(b)) are
also compatible with the molecular structure of 2. These
results confirm the assumption that 2,4-AMT would be a
possible oxidation end-product of MTF in aqueous solution.
Ions at m/z 126.1 were difficult to observe as they could
arise from aromatic compounds (triazines), usually very
difficult to fragment. By accumulating a lot of scans when
working in MS infusion, a correct CID spectrum was finally
obtained. However, this CID spectrum corresponds to a
mixture of the two peaks detected at m/z 126.1 by HPLC/MS.
Indeed, the accumulation time, equal to the peak width,
was not sufficient to obtain valuable MS/MS information
(intensities are too low) when we tried to obtain the CID
spectra for the individual HPLC peaks.
Finally, other experiments using nuclear magnetic res-
onance (NMR) and high-resolution Fourier transform ion
cyclotron resonance (FT-ICR) methods in the search for
additional data for structure elucidation were carried out in
order to provide elements of confirmation for the proposed
structures of the products detected at m/z 126.1. However,
no valuable information was obtained since dilute aqueous
solution (radiolysis conditions) is not a good medium for
NMR work and the mass of metformin (129 g molꢀ1) is too
low to work correctly with FT-ICR.
Identification of secondary oxidation products
As previously explained (see Experimental section), sec-
ondary oxidation products are generated at high radia-
tion doses (above 50 Gy) and are the result of the attack
of HOž radicals on some of the primary oxidation end-
products. Based on MS identifications, a general reaction
mechanism has been postulated, that includes four differ-
ent reactions (covalent dimerization, peroxidation, double
dehydrogenation, demethylation). Since the molecular struc-
tures of primary oxidation end-products and the reactions
involved in their formation have been characterized, molec-
ular structures were deduced for each secondary oxidation
end-product and are presented in Table 2.
The heaviest secondary oxidation product is detected
at m/z 384.1 and could correspond to a covalent trimer of
MTF (called triMTF). Full mass and CID spectra confirm
this assumption. A doubly protonated ion is detected at m/z
192.6, indicating that this ion contains at least two potential
sites for protonation. The triply charged ion that could be
detected at m/z 128.7 is not clearly identified because of a lack
of resolution of the mass spectrometer: it should be observed
together with the peak at m/z 129.1, the doubly protonated
diMTF. The full mass spectrum for a solution of oxidized
MTF (300 Gy, deaerated conditions) diluted in D2O–MeOD
(1 : 1) shows a peak at m/z 400.3, due to 16 H–D exchanges
on the ion of m/z 384.1, which confirms the formation of
two carbon–carbon single bonds (triMTF contains three
molecules of MTF that can exchange 3 ð 5 D 15 times plus
one for protonation). Finally, the CID spectrum of m/z 384.1
exhibits three losses of 17 and 42 Da, as previously observed
for diMTF (see Fig. 6(b)). These observations confirm that
a covalent trimer of MTF is one the secondary oxidation
end-products.
The next two products, detected at m/z 253.1 and
243.1, could come from the double dehydrogenation
and the demethylation of diMTF, respectively, and are
called 4-amino-2-imino-1-[2-(1-methylbiguanid-1-yl)ethyl]-
1,2-dihydro-1,3,5-triazine (4,2,1-AIBT) and N-demethyldi-
metformin (DMdiMTF). Actually, DMdiMTF could also be
generated by a radical–radical reaction between an MTF rad-
ical and an MBG radical (both carbon-centered). Full mass
and CID data provide elements of confirmation for these
proposals. For 4,2,1-AIBT, no peak at m/z 127 is detected,
meaning that the double protonation of its parent ion is not
easy, probably because of the cyclic part of this molecule
(in relation to MTF). Concerning DMdiMTF, the doubly
protonated molecule is detected at m/z 122.1, and the CID
spectrum of this last ion exhibits fragment ions at m/z
113.6, 85.1 and 60.1, which are typical MTF fragments as
determined previously (see Fig. 3).
The last reaction that could have been applied to diMTF,
to find another product, could be peroxidation. However,
all of these products (diMTF, triMTF, 4,2,1-AIBT and
DMdiMTF) are generated only under deaerated conditions;
peroxidation was made impossible because of the absence of
molecular oxygen.
NHCH3
N
NH
CH3
N
N
N
N
H2N
N
H2N
(2)
(1)
Figure 14. Proposed mechanism involved in the formation of
the second ion detected at m/z 126.1 during HOž
radical-induced oxidation of metformin in solution.
The other secondary oxidation products could come
from reactions on MBG: covalent dimerization, peroxidation,
double dehydrogenation and demethylation that could
Copyright 2004 John Wiley & Sons, Ltd.
J. Mass Spectrom. 2004; 39: 890–902